In such neoplasms, the thyroidal component exhibits immunoreactivity for thyroid transcription factor-1 (TTF-1) and thyroglobulin (TG), whereas these markers are not typically expressed in the carcinoid component [5, 6]. This evidence concerns the gene TTF1 and carcinoid tumor.